Clinical Trial Update: Vitamin D in Bronchiolitis Obliterans Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the use of Vitamin D for bronchiolitis obliterans syndrome in lung transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Rejection
• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Allograft Rejection, Lung Transplantation | Phase 4 | Status: COMPLETED